Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an <i>In Vitro</i> Pharmacodynamic Model.

Beganovic, Maya; Daffinee, Kathryn E; Luther, Megan K; LaPlante, Kerry L

Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model.

Beganovic, Maya; Daffinee, Kathryn E; Luther, Megan K; LaPlante, Kerry L.

Afiliação

Beganovic M; Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, Rhode Island, USA.
Daffinee KE; College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA.
Luther MK; Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, Rhode Island, USA.
LaPlante KL; Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, Rhode Island, USA.

Antimicrob Agents Chemother ; 65(3)2021 02 17.

Article em En | MEDLINE | ID: mdl-33318006

Assuntos

Infecções por Acinetobacter; Acinetobacter baumannii; Infecções por Acinetobacter/tratamento farmacológico; Antibacterianos/farmacologia; Antibacterianos/uso terapêutico; Carbapenêmicos/farmacologia; Sinergismo Farmacológico; Humanos; Meropeném/farmacologia; Testes de Sensibilidade Microbiana; Minociclina/farmacologia; Polimixina B/farmacologia; Sulbactam/farmacologia

Palavras-chave

Acinetobacter baumannii; beta-lactams; continuous infusion; minocycline; polymyxin B

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Acinetobacter / Acinetobacter baumannii Limite: Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google